Poster will feature RNA primed SMAR-T™ cells against multiple cancer driver mutations NATICK, Mass., April 14, 2023 /PRNewswire/ — Geneius Biotechnology, Inc., an immuno-oncology company developing a best-in-class personalized RNA-enabled T cell therapy platform that generates a robust…